Ajooni Biotech Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajooni Biotech Limited has filed a disclosure with the stock exchange as required under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters of listed companies to disclose details of their shareholding, including any encumbrances such as pledges. The filing itself is a routine compliance submission and does not, on its own, indicate any transaction or change in ownership. The actual content of the disclosure (e.g., whether promoter holdings, pledges, or encumbrances have changed) is not specified in the headline. Investors would need to review the attached disclosure document for specific details on shareholding patterns.
This is a routine regulatory filing and is unlikely to have any immediate impact on the stock price. Shareholders should review the attached disclosure document to check for any changes in promoter holdings, pledges, or encumbrances that could affect their investment.